Litcius/Paper detail

Salivary Fusobacterium nucleatum serves as a potential biomarker for colorectal cancer

Xin Zhang, Yaping Zhang, Xinru Gui, Yanli Zhang, Zhenhong Zhang, Wendan Chen, Xiaowei Zhang, Yanxiang Wang, Mengjiao Zhang, Ziqi Shang, Yiwei Xin, Yi Zhang, Yiwei Xin, Yi Zhang, Yi Zhang

2022iScience36 citationsDOIOpen Access PDF

Abstract

(Fn) is primarily colonized in the oral cavity. Recently, Fn has been closely associated with the tumorigenesis of colorectal cancer (CRC). Here, we showed that the relative level of Fn DNA was increased in the saliva of the CRC group compared with the normal colonoscopy, hyperplastic polyp, and adenoma groups. Receiver operating characteristic curve analysis illustrated that Fn DNA was superior to carcinoembryonic antigen and carbohydrate antigen 19-9 in CRC diagnosis. Moreover, levels of Fn DNA were associated with the overall survival and disease-free survival of CRC patients, which was an independent factor for prognostic prediction. Transcriptome sequencing identified 1,287 differentially expressed mRNAs in tumor tissues between CRC patients with high-Fn and low-Fn infection. Kyoto encyclopedia of genes and genomes analysis showed that ECM-receptor interaction and focal adhesion were the top two significant pathways. Overall, salivary Fn DNA may be a noninvasive diagnostic and prognostic biomarker for CRC patients.

Topics & Concepts

Fusobacterium nucleatumColorectal cancerCarcinoembryonic antigenBiomarkerSalivaTranscriptomeCancerCarcinogenesisCancer researchSurgical oncologyMedicineInternal medicineBiologyOncologyGeneGene expressionGeneticsPeriodontitisPorphyromonas gingivalisSalivary Gland Tumors Diagnosis and TreatmentHead and Neck Cancer StudiesMycobacterium research and diagnosis
Salivary Fusobacterium nucleatum serves as a potential biomarker for colorectal cancer | Litcius